Compare Brevis (BREV) vs Mitosis (MITO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Mitosis — how do they compare? Brevis trades at Rp1,339 (market cap Rp335,51M, Rp233,16M 24h volume), while Mitosis trades at Rp389.4 (market cap Rp70,59M, Rp76,52M 24h volume). The key difference: Brevis is far larger — about 4.8× Mitosis's market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 6 Days and Mitosis for 19 Days on average.
| BREV | MITO | |
|---|---|---|
Market Cap | Rp335,51M | Rp70,59M |
Volume (24h) | Rp233,16M | Rp76,52M |
Circulating Supply | 250M / 1B BREV (25%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 6 Days | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) shows mixed technical signals with an overall bullish bias despite bearish moving averages. The token trades at Rp1,345.9 with a market cap of Rp333.86 million and 25% circulating supply. Key technical indicators show RSI_6 at 27.08 (oversold) and strong ADX readings suggesting trending momentum. Support levels are established at Rp1,256-Rp1,335 while resistance sits at Rp1,413-Rp1,492.
Overall outlook suggests cautious optimism with oversold RSI signaling potential rebound. Key opportunities include technical bounce from support levels, while major risks involve limited liquidity (Rp333.86M market cap) and absence of recent protocol updates. Investors should monitor volume confirmation for sustained moves.
MITO is trading at Rp389.78 with a bearish technical signal from moving averages, though oscillators are neutral. Current price is near the pivot point of Rp390, with support at Rp368 and resistance at Rp403. The token has a low circulating supply of 19% (181,300 out of 1M max supply) and an average hold time of 19 days. Recent news mentions a corporate acquisition, but as a cryptocurrency, focus remains on token metrics and market dynamics.
Outlook: Bearish short-term due to weak moving averages, but oversold RSI hints at potential rebound. Key risks include low liquidity (market cap Rp70.44M) and limited network activity. Opportunities exist if token utility expands, but caution is advised given thin trading volumes and minimal ecosystem updates.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →
